比亞迪電子(00285.HK)續跌逾3% 首季盈利及毛利率降均遜預期
首季盈利遜於市場預期的比亞迪電子(00285.HK)承昨天股價以大成交急吐12%一舉失守4條移動平均線勢,今天反覆低見40.8元,現造41.35元,續跌3.3%,成交1,191萬股。
比亞迪電子昨天公布,首季多賺23%至8.08億人民幣,期內毛利率環比降3.5個百分點至6.4%遜於預期。瑞信指比亞迪電子首季純利符該行預期,但遜於市場預期。不過,公司維持今年1,000億元人民幣銷售目標,主要受惠蘋果(AAPL.US)及電子煙公司增長推動,故上調公司未來三年盈利0.5%/9%/7%,目標價微升至42元,維持「中性」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.